The Valley Desk

NCT05262517 · Interventional trial

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

Overall registry status Terminated

Phase 3

Conditions Temporomandibular Disorders (TMD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov